NCT07033429

Brief Summary

Thiol-disulfide Homeostasis (TDH) is essential for physiological functions in the human reproductive system, including antioxidant defense, detoxification, signal transduction, enzymatic regulation, apoptosis, and cellular communication. Ischemia-Modified Albumin (IMA) serves as an indicator of oxidative stress (OS) and is linked to ischemia-reperfusion injury. This study aimed to investigate changes in OS markers, particularly TDH and IMA levels, in couples with male infertility, and to examine the relationship between these markers and in vitro fertilization (IVF) success. Understanding how TDH and IMA levels influence IVF outcomes is crucial for advancing reproductive treatments for couples having diagnosis of infertility.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
122

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Apr 2023

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2023

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 31, 2023

Completed
1.6 years until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2025

Completed
12 days until next milestone

First Submitted

Initial submission to the registry

June 13, 2025

Completed
11 days until next milestone

First Posted

Study publicly available on registry

June 24, 2025

Completed
Last Updated

June 24, 2025

Status Verified

April 1, 2023

Enrollment Period

7 months

First QC Date

June 13, 2025

Last Update Submit

June 13, 2025

Conditions

Keywords

infertilityin vitro fertilizationischemia-modified albuminmale factorthiol-disulfide homeostasisunexplained

Outcome Measures

Primary Outcomes (3)

  • Live birth rate (LBR)

    live births to the total number of embryo transfer cycles

    6 months

  • beta-human chorionic gonadotropin (hCG) positivity

    serum ≥ 10 mlU/mL

    6 months

  • clinical pregnancy (CP)

    the detection of a gestational sac via transvaginal ultrasonography

    6 months

Secondary Outcomes (1)

  • diagnosing male infertility

    6 months

Study Arms (2)

Study Group

undergoing IVF due to male factor infertility

control group

undergoing IVF due to unexplained infertility

Eligibility Criteria

Age23 Years - 45 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Couples in which women aged 23-45 years and undergoing IVF treatment due to male factor and unexplained infertility were enrolled.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Bilkent City Hospital

Ankara, 06800, Turkey (Türkiye)

Location

Related Publications (3)

  • Micoogullari U, Cakici MC, Kilic FU, Kisa E, Ozcift B, Caglayan A, Neselioglu S, Karatas OF, Erel O. Evaluation of the role of thiol / disulfide homeostasis in the etiology of idiopathic male infertility with a novel and automated assay. Syst Biol Reprod Med. 2022 Apr;68(2):162-168. doi: 10.1080/19396368.2021.2003481. Epub 2021 Dec 10.

    PMID: 34893004BACKGROUND
  • Zec I, Goldstajn MS, Kuna K, Mikus M, Stabile G, Bianco B, Buzzaccarini G, Lagana AS. Oxidative homeostasis in follicular fluid and reproductive outcomes - from bench to bedside. Prz Menopauzalny. 2022 Dec;21(4):276-284. doi: 10.5114/pm.2022.124019. Epub 2022 Dec 30.

    PMID: 36704764BACKGROUND
  • Ozdemir AZ, Karli P, Neseli Oglu S. Does thiol/disulfide homeostasis affect the number of metaphase 2 oocyte in the treatment of in vitro fertilization? Future Sci OA. 2020 Jan 14;6(2):FSO452. doi: 10.2144/fsoa-2019-0132.

    PMID: 32025332BACKGROUND

Biospecimen

Retention: SAMPLES WITHOUT DNA

Serum samples were collected from the males on the day of oocyte pick-up. Blood samples were drawn from the antecubital vein and transferred into gel-based biochemistry tubes for the determination of TDH, IMA and other biochemical parameters.

MeSH Terms

Conditions

Infertility

Condition Hierarchy (Ancestors)

Genital DiseasesUrogenital Diseases

Study Officials

  • Müzeyyen Gülnur Özakşit, M.D., Professor

    Ankara Bilkent City Hospital, IVF Unit

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
6 Months
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
M.D., Professor

Study Record Dates

First Submitted

June 13, 2025

First Posted

June 24, 2025

Study Start

April 1, 2023

Primary Completion

October 31, 2023

Study Completion

June 1, 2025

Last Updated

June 24, 2025

Record last verified: 2023-04

Data Sharing

IPD Sharing
Will share

All of the data including demographic characteristics and laboratory findings.

Shared Documents
STUDY PROTOCOL, SAP, ICF, CSR
Time Frame
From the beginning of study up to now.

Locations